Dedicated to Discovery. Committed to Care.

Dana-Farber Brigham and Women's Cancer Center Banner

Gynecologic Cancer Treatment Center

Diseases Treated

Cervical Cancer

Clinical trials for Cervical cancer

If you're interested in a cervical cancer clinical trial, please contact one of our Gyn Oncology Research Nurses:

Julie Lee, RN (617) 632-4975
Christin Whalen (617) 582-7738

Protocol 05-020: PTK787 Plus Docetaxel for Recurrent Mullerian Malignancies

This is a Phase II study to measure the effectiveness of oral PTK787, a drug that blocks angiogenesis, and docetaxel (taxotere), given weekly intravenously. Another aspect of this study is to test the effect of this drug combination on special MRI scans, called DC-MRI scans.

More cervical cancer clinical trials

Please continue to check this site for updates. New clinical trials for cervical cancer are added regularly.

Entering a Clinical Trial; Is it Right for You?